MCB-613 exploits a collateral sensitivity in drug resistant EGFR -mutant non-small cell lung cancer through covalent inhibition of KEAP1 is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1F31CA195967-01
Mapping the landscape of drug sensitizers in human cancers
National Institutes of Health
Grant: 1F30CA247323-01
Identification and Characterization of Novel Cis-Regulatory Elements Controlling PTEN Expression
National Institutes of Health
Grant: 5T32GM007171-17
MEDICAL SCIENTIST
National Institutes of Health
Grant: 4K00CA245732-02
Uncovering actionable signaling pathways required for solid tumor brain metastasis
National Science Foundation
Grant: 1106401
GRADUATE RESEARCH FELLOWSHIP PROGRAM
National Institutes of Health
Grant: 5F99CA264162-02
Understanding the impact that tumor representative oxygen tension has on phosphotyrosine-dependent signaling networks in solid tumors
National Institutes of Health
Grant: 5R01CA263593-03
Mechanism-based targeting of unique survival signaling in residual tumors
NCI NIH HHS
Grant: K00 CA245732
NCI NIH HHS
Grant: F30 CA247323
NCI NIH HHS
Grant: F31 CA195967
NCI NIH HHS
Grant: F99 CA264162
NCI NIH HHS
Grant: R01 CA263593
NIGMS NIH HHS
Grant: T32 GM145449
NIGMS NIH HHS
Grant: T32 GM007171
Fields of Study
Keywords
Sustainable Development Goals